HRMY
$28.46
Revenue | $201.27Mn |
Net Profits | $49.48Mn |
Net Profit Margins | 24.58% |
Harmony Biosciences Holdings Inc’s revenue jumped 19.51% since last year same period to $201.27Mn in the Q4 2024. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 8.19% jump in its revenue since last 3-months.
Harmony Biosciences Holdings Inc’s net profit jumped 85.95% since last year same period to $49.48Mn in the Q4 2024. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 7.34% jump in its net profits since last 3-months.
Harmony Biosciences Holdings Inc’s net profit margin jumped 55.59% since last year same period to 24.58% in the Q4 2024. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated -0.78% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.82 |
EPS Estimate Current Year | 0.82 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.82 - a 21.96% jump from last quarter’s estimates.
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.82.
Earning Per Share (EPS) | 1.08 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) jumped 140% since last year same period to 1.08 in the Q4 2024. This indicates that the Harmony Biosciences Holdings Inc has generated 140% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-02-25 | 0.82 | 1.08 | 32.17% |
2024-08-06 | -0.06 | 0.2 | 433.33% |
2024-04-30 | 0.6 | 0.67 | 11.67% |
2024-10-29 | 0.67 | 0.79 | 17.91% |